Evrofarma Balance Sheet Health
Financial Health criteria checks 4/6
Evrofarma has a total shareholder equity of €15.4M and total debt of €22.9M, which brings its debt-to-equity ratio to 148.3%. Its total assets and total liabilities are €54.1M and €38.6M respectively. Evrofarma's EBIT is €4.5M making its interest coverage ratio 4.1. It has cash and short-term investments of €2.0M.
Key information
148.3%
Debt to equity ratio
€22.90m
Debt
| Interest coverage ratio | 4.1x |
| Cash | €2.02m |
| Equity | €15.44m |
| Total liabilities | €38.64m |
| Total assets | €54.09m |
Recent financial health updates
Evrofarma (ATH:EVROF) Has A Somewhat Strained Balance Sheet
Dec 01
Is Evrofarma (ATH:EVROF) Using Too Much Debt?
May 27Recent updates
Subdued Growth No Barrier To Evrofarma SA (ATH:EVROF) With Shares Advancing 30%
Feb 29Evrofarma SA (ATH:EVROF) Stock Rockets 33% But Many Are Still Ignoring The Company
Jan 06Returns On Capital At Evrofarma (ATH:EVROF) Have Stalled
Jan 05Evrofarma (ATH:EVROF) Has A Somewhat Strained Balance Sheet
Dec 01Here's What's Concerning About Evrofarma's (ATH:EVROF) Returns On Capital
Sep 15Is Evrofarma (ATH:EVROF) Using Too Much Debt?
May 27We Think That There Are Issues Underlying Evrofarma's (ATH:EVROF) Earnings
Oct 04Returns On Capital At Evrofarma (ATH:EVROF) Paint A Concerning Picture
May 19Should Evrofarma SA (ATH:EVROF) Focus On Improving This Fundamental Metric?
Feb 22Be Wary Of Evrofarma (ATH:EVROF) And Its Returns On Capital
Dec 29
Is Evrofarma SA's (ATH:EVROF) 2.2% ROE Worse Than Average?
Nov 22Financial Position Analysis
Short Term Liabilities: EVROF's short term assets (€24.1M) exceed its short term liabilities (€17.5M).
Long Term Liabilities: EVROF's short term assets (€24.1M) exceed its long term liabilities (€21.2M).
Debt to Equity History and Analysis
Debt Level: EVROF's net debt to equity ratio (135.1%) is considered high.
Reducing Debt: EVROF's debt to equity ratio has reduced from 170.1% to 148.3% over the past 5 years.
Debt Coverage: EVROF's debt is not well covered by operating cash flow (11.1%).
Interest Coverage: EVROF's interest payments on its debt are well covered by EBIT (4.1x coverage).